The biotech industry, which requires ongoing progress, is anticipated to be affected by high-interest rates and uncertainty. Hence, in this article, let's take a look at biotech stocks Bionano Genomics, Inc. (BNGO), VBI Vaccines Inc. (VBIV), and 180 Life Sciences Corp. (ATNF) and discuss why it's best to sell these stocks as soon as possible.
Last year was transitional for the biotech industry following significant investments and public recognition for COVID-related treatments and vaccines. However, interest rates are expected to remain high, which could impact the value of risky assets such as biotech stocks. Also, the IPO market slowed down in 2022, causing uncertainty for biotech companies as they plan for this year.
